Across TCGA pan-cancer cohorts, TRIM64B RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated TRIM64B data layer.
The strongest signal is observed in uterine carcinosarcoma (UCS), where higher TRIM64B RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TRIM64B expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.
UCS, KIRC, and KICH are the cancer types where TRIM64B RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.